05 Jan FOCUS-Drug developers take fresh aim at ‘guided-missile’ cancer drugs
Dozens of drugmakers are
conducting human trials for a record 89 therapies that pair
antibodies with toxic agents to fight cancer, evidence of
renewed confidence in an approach that has long fallen short of
its promise, an analysis compiled for Reuters shows.
conducting human trials for a record 89 therapies that pair
antibodies with toxic agents to fight cancer, evidence of
renewed confidence in an approach that has long fallen short of
its promise, an analysis compiled for Reuters shows.
Sorry, the comment form is closed at this time.